Treatment of autoimmune disease by adoptive cellular gene therapy - PubMed (original) (raw)
Review
Treatment of autoimmune disease by adoptive cellular gene therapy
Ingo H Tarner et al. Ann N Y Acad Sci. 2003 Sep.
Abstract
Autoimmune disorders represent inappropriate immune responses directed at self-tissue. Antigen-specific CD4+ T cells and antigen-presenting dendritic cells (DCs) are important mediators in the pathogenesis of auto-immune disease and thus are ideal candidates for adoptive cellular gene therapy, an ex vivo approach to therapeutic gene transfer. Using retrovirally transduced cells and luciferase bioluminescence, we have demonstrated that primary T cells, T cell hybridomas, and DCs rapidly and preferentially home to the sites of inflammation in animal models of multiple sclerosis, arthritis, and diabetes. These cells, transduced with retroviral vectors to drive expression of various "regulatory proteins" such as IL-4, IL-10, IL-12p40, and anti-TNF scFv, deliver these immunoregulatory proteins to the inflamed lesions, providing therapy for experimental autoimmune encephalitis (EAE), collagen-induced arthritis (CIA), and nonobese diabetic mice (NOD).
Similar articles
- Adoptive cellular gene therapy of autoimmune disease.
Slavin AJ, Tarner IH, Nakajima A, Urbanek-Ruiz I, McBride J, Contag CH, Fathman CG. Slavin AJ, et al. Autoimmun Rev. 2002 Aug;1(4):213-9. doi: 10.1016/s1568-9972(02)00051-4. Autoimmun Rev. 2002. PMID: 12848998 Review. - Adoptive Cellular Gene Therapy for the Treatment of Experimental Autoimmune Polychondritis Ear Disease.
Zhou B, Liao Y, Guo Y, Tarner IH, Liao C, Chen S, Kermany MH, Tu H, Zhong S, Chen P. Zhou B, et al. ORL J Otorhinolaryngol Relat Spec. 2017;79(3):166-177. doi: 10.1159/000452767. Epub 2017 May 3. ORL J Otorhinolaryngol Relat Spec. 2017. PMID: 28463837 - Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis.
Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG. Nakajima A, et al. J Clin Invest. 2001 May;107(10):1293-301. doi: 10.1172/JCI12037. J Clin Invest. 2001. PMID: 11375419 Free PMC article. - Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.
Dal Canto RA, Costa G, Shaw MD, Seroogy C, Nolan GP, Fathman CG. Dal Canto RA, et al. Eur Cytokine Netw. 1998 Sep;9(3 Suppl):83-91. Eur Cytokine Netw. 1998. PMID: 9831193 - Gene therapy in autoimmune disease.
Tarner IH, Fathman CG. Tarner IH, et al. Curr Opin Immunol. 2001 Dec;13(6):676-82. doi: 10.1016/s0952-7915(01)00278-3. Curr Opin Immunol. 2001. PMID: 11677089 Review.
Cited by
- Exploring Novel Treatment Modalities for Type 1 Diabetes Mellitus: Potential and Prospects.
Salama RAA, Patni MAMF, Ba-Hutair SNM, Wadid NA, Akikwala MS. Salama RAA, et al. Healthcare (Basel). 2024 Jul 26;12(15):1485. doi: 10.3390/healthcare12151485. Healthcare (Basel). 2024. PMID: 39120188 Free PMC article. Review. - Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice.
Henningsson L, Eneljung T, Jirholt P, Tengvall S, Lidberg U, van den Berg WB, van de Loo FA, Gjertsson I. Henningsson L, et al. PLoS One. 2012;7(11):e49731. doi: 10.1371/journal.pone.0049731. Epub 2012 Nov 16. PLoS One. 2012. PMID: 23166758 Free PMC article. - In situ induction of dendritic cell-based T cell tolerance in humanized mice and nonhuman primates.
Jung KC, Park CG, Jeon YK, Park HJ, Ban YL, Min HS, Kim EJ, Kim JH, Kang BH, Park SP, Bae Y, Yoon IH, Kim YH, Lee JI, Kim JS, Shin JS, Yang J, Kim SJ, Rostlund E, Muller WA, Park SH. Jung KC, et al. J Exp Med. 2011 Nov 21;208(12):2477-88. doi: 10.1084/jem.20111242. Epub 2011 Oct 24. J Exp Med. 2011. PMID: 22025302 Free PMC article. - Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?
Phillips B, Trucco M, Giannoukakis N. Phillips B, et al. Clin Dev Immunol. 2011;2011:432016. doi: 10.1155/2011/432016. Epub 2011 Jul 18. Clin Dev Immunol. 2011. PMID: 21785616 Free PMC article. Review. - Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.
Di Caro V, D'Anneo A, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Di Caro V, et al. Immunol Res. 2011 Aug;50(2-3):130-52. doi: 10.1007/s12026-011-8206-1. Immunol Res. 2011. PMID: 21476100
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials